171 related articles for article (PubMed ID: 23823800)
21. Age-dependent loss of insulin-like growth factor-1 receptor immunoreactive cells in the supraoptic hypothalamus is reduced in calorically restricted mice.
Yaghmaie F; Saeed O; Garan SA; Voelker MA; Gouw AM; Freitag W; Sternberg H; Timiras PS
Int J Dev Neurosci; 2006 Nov; 24(7):431-6. PubMed ID: 17034982
[TBL] [Abstract][Full Text] [Related]
22. R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts.
Kolb EA; Kamara D; Zhang W; Lin J; Hingorani P; Baker L; Houghton P; Gorlick R
Pediatr Blood Cancer; 2010 Jul; 55(1):67-75. PubMed ID: 20486173
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone.
Nordstrand A; Bergström SH; Thysell E; Bovinder-Ylitalo E; Lerner UH; Widmark A; Bergh A; Wikström P
Clin Exp Metastasis; 2017 Apr; 34(3-4):261-271. PubMed ID: 28447314
[TBL] [Abstract][Full Text] [Related]
24. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.
Lashinger LM; Malone LM; Brown GW; Daniels EA; Goldberg JA; Otto G; Fischer SM; Hursting SD
Cancer Prev Res (Phila); 2011 Jul; 4(7):1041-51. PubMed ID: 21593197
[TBL] [Abstract][Full Text] [Related]
26. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
27. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.
Mavropoulos JC; Buschemeyer WC; Tewari AK; Rokhfeld D; Pollak M; Zhao Y; Febbo PG; Cohen P; Hwang D; Devi G; Demark-Wahnefried W; Westman EC; Peterson BL; Pizzo SV; Freedland SJ
Cancer Prev Res (Phila); 2009 Jun; 2(6):557-65. PubMed ID: 19470786
[TBL] [Abstract][Full Text] [Related]
28. Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.
Harvey AE; Lashinger LM; Hays D; Harrison LM; Lewis K; Fischer SM; Hursting SD
PLoS One; 2014; 9(5):e94151. PubMed ID: 24804677
[TBL] [Abstract][Full Text] [Related]
29. The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.
Kurmasheva RT; Dudkin L; Billups C; Debelenko LV; Morton CL; Houghton PJ
Cancer Res; 2009 Oct; 69(19):7662-71. PubMed ID: 19789339
[TBL] [Abstract][Full Text] [Related]
30. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.
Mitran B; Altai M; Hofström C; Honarvar H; Sandström M; Orlova A; Tolmachev V; Gräslund T
Amino Acids; 2015 Feb; 47(2):303-15. PubMed ID: 25425114
[TBL] [Abstract][Full Text] [Related]
32. The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas.
Fleuren ED; Versleijen-Jonkers YM; Heskamp S; Roeffen MH; Bouwman WH; Molkenboer-Kuenen JD; van Laarhoven HW; Oyen WJ; Boerman OC; van der Graaf WT
Eur J Cancer; 2013 Sep; 49(13):2851-8. PubMed ID: 23664098
[TBL] [Abstract][Full Text] [Related]
33. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
34. Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice.
Buschemeyer WC; Klink JC; Mavropoulos JC; Poulton SH; Demark-Wahnefried W; Hursting SD; Cohen P; Hwang D; Johnson TL; Freedland SJ
Prostate; 2010 Jul; 70(10):1037-43. PubMed ID: 20166128
[TBL] [Abstract][Full Text] [Related]
35. An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer.
Plymate SR; Haugk K; Coleman I; Woodke L; Vessella R; Nelson P; Montgomery RB; Ludwig DL; Wu JD
Clin Cancer Res; 2007 Nov; 13(21):6429-39. PubMed ID: 17975155
[TBL] [Abstract][Full Text] [Related]
36. Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507.
Fleuren ED; Versleijen-Jonkers YM; van de Luijtgaarden AC; Molkenboer-Kuenen JD; Heskamp S; Roeffen MH; van Laarhoven HW; Houghton PJ; Oyen WJ; Boerman OC; van der Graaf WT
Clin Cancer Res; 2011 Dec; 17(24):7693-703. PubMed ID: 22038993
[TBL] [Abstract][Full Text] [Related]
37. Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.
Shang Y; Mao Y; Batson J; Scales SJ; Phillips G; Lackner MR; Totpal K; Williams S; Yang J; Tang Z; Modrusan Z; Tan C; Liang WC; Tsai SP; Vanderbilt A; Kozuka K; Hoeflich K; Tien J; Ross S; Li C; Lee SH; Song A; Wu Y; Stephan JP; Ashkenazi A; Zha J
Mol Cancer Ther; 2008 Sep; 7(9):2599-608. PubMed ID: 18790743
[TBL] [Abstract][Full Text] [Related]
38. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.
Ngo TH; Barnard RJ; Cohen P; Freedland S; Tran C; deGregorio F; Elshimali YI; Heber D; Aronson WJ
Clin Cancer Res; 2003 Jul; 9(7):2734-43. PubMed ID: 12855654
[TBL] [Abstract][Full Text] [Related]
39. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.
Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Oyen WJ; van der Graaf WT; van Laarhoven HW
Int J Cancer; 2013 Jul; 133(2):307-14. PubMed ID: 23335047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
